Literature DB >> 15215143

Comparison of artesunate and chloroquine activities against Plasmodium vivax gametocytes.

Mathieu Nacher1, Udomsak Silachamroon, Pratap Singhasivanon, Polrat Wilairatana, Weerapong Phumratanaprapin, Arnaud Fontanet, Sornchai Looareesuwan.   

Abstract

The gametocidal activities of chloroquine and artesunate were compared. The relative risk (RR) of having detectable gametocytes appear after treatment initiation was lower in artesunate-treated patients (n = 792) than in chloroquine-treated patients (n = 695) (RR = 0.29; 95% CI = 0.2 to 0.40; P < 0.0001). The duration and magnitude of gametocyte carriage were also lower for artesunate than chloroquine. By reducing the transmission of Plasmodium vivax to the vector, artesunate could therefore reduce the incidence of P. vivax malaria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15215143      PMCID: PMC434160          DOI: 10.1128/AAC.48.7.2751-2752.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Hidden Plasmodium falciparum infections.

Authors:  S Krudsood; P Wilairatana; D P Mason; S Treeprasertsuk; P Singhasivanon; S Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  1999-12       Impact factor: 0.267

2.  Therapeutic responses to different antimalarial drugs in vivax malaria.

Authors:  S Pukrittayakamee; A Chantra; J A Simpson; S Vanijanonta; R Clemens; S Looareesuwan; N J White
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

3.  Effects of artemisinin derivatives on malaria transmissibility.

Authors:  R N Price; F Nosten; C Luxemburger; F O ter Kuile; L Paiphun; T Chongsuphajaisiddhi; N J White
Journal:  Lancet       Date:  1996-06-15       Impact factor: 79.321

4.  Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.

Authors:  Udomsak Silachamroon; Srivicha Krudsood; Sombat Treeprasertsuk; Polrat Wilairatana; Kobsiri Chalearmrult; Hla Yin Mint; Pannamas Maneekan; Nicholas J White; Victor R Gourdeuk; Gary M Brittenham; Sornchai Looareesuwan
Journal:  Am J Trop Med Hyg       Date:  2003-07       Impact factor: 2.345

  4 in total
  8 in total

Review 1.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

Review 2.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 3.  Artemisinin combination therapy for vivax malaria.

Authors:  Nicholas M Douglas; Nicholas M Anstey; Brian J Angus; Francois Nosten; Ric N Price
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

4.  Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand.

Authors:  Noppadon Tangpukdee; Srivicha Krudsood; Siripan Srivilairit; Nanthaporn Phophak; Putza Chonsawat; Wimon Yanpanich; Shigeyuki Kano; Polrat Wilairatana
Journal:  Korean J Parasitol       Date:  2008-06       Impact factor: 1.341

5.  Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum.

Authors:  Samuel Dunyo; Paul Milligan; Tansy Edwards; Colin Sutherland; Geoffrey Targett; Margaret Pinder
Journal:  PLoS Clin Trials       Date:  2006-08-18

6.  Early transmission of sensitive strain slows down emergence of drug resistance in Plasmodium vivax.

Authors:  Mario J C Ayala; Daniel A M Villela
Journal:  PLoS Comput Biol       Date:  2020-06-17       Impact factor: 4.475

Review 7.  Transmission-blocking strategies: the roadmap from laboratory bench to the community.

Authors:  Daniel Gonçalves; Patrick Hunziker
Journal:  Malar J       Date:  2016-02-18       Impact factor: 2.979

Review 8.  The mechanisms of action of Plasmodium infection against cancer.

Authors:  Xiaoping Chen; Li Qin; Wen Hu; Dickson Adah
Journal:  Cell Commun Signal       Date:  2021-07-09       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.